Abstract
Pharmaceutical Research and Manufacturers of America (PhRMA) has formed a Working Group on Adaptive Designs. The group aims to contribute to a constructive dialogue on adaptive designs by engaging statisticians, clinicians, and other stakeholders in academia, regulatory agencies, and industry. Hopefully this will facilitate broader consideration and implementation of these designs. The papers that follow in this issue comprise the Full White Paper of the group and summarize its findings and recommendations from its first year of activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
